| Literature DB >> 34864953 |
Luo Zhao1, Jia He1, Yingzhi Qin1, Hongsheng Liu1, Shanqing Li1, Zhijun Han1, Li Li1.
Abstract
BACKGROUND: Mediastinal lymphadenectomy is of great importance during esophagectomy for esophageal squamous cell carcinoma. However, recurrent laryngeal nerve (RLN) injury is a severe complication caused by lymphadenectomy along the RLN. Intraoperative nerve monitoring (IONM) can effectively identify the RLN and reduce the incidence of postoperative vocal cord paralysis (VCP). Here, we describe the feasibility and effectiveness of IONM in minimally invasive McKeown esophagectomy.Entities:
Keywords: McKeown esophagectomy; esophagus; intraoperative nerve monitoring; recurrent laryngeal nerve
Mesh:
Year: 2022 PMID: 34864953 PMCID: PMC9277452 DOI: 10.1093/dote/doab080
Source DB: PubMed Journal: Dis Esophagus ISSN: 1120-8694 Impact factor: 2.822
Fig. 1IONM detection of RLN. A. We use IONM to detect the right RLN and obtain EMG waveform amplitude R1 before visualization. B. We detected the right RLN again and obtained EMG waveform amplitude R2 after dissection. C. We detected the left RLN and obtained EMG waveform amplitude L1 before visualization. D. We detected the left RLN and obtained EMG waveform amplitude L2 after dissection. VN, vagus nerve; RLN, recurrent laryngeal nerve; Eso, esophagus; TR, trachea; Probe, stimulator probe; PA pulmonary artery; Ao Arcgh, arotic arch
Baseline characteristics
| Variables | IONM group ( | Control group ( |
|
|---|---|---|---|
| Age (years) | 62.99 ± 8.81 | 61.96 ± 7.12 | 0.433 |
| Sex | 0.571 | ||
| Male | 59 | 70 | |
| Female | 11 | 10 | |
| Tumor location | 0.927 | ||
| Upper | 5 | 6 | |
| Middle | 45 | 49 | |
| Lower | 20 | 25 | |
| Neoadjuvant therapy | |||
| No | 45 | 57 | 0.615 |
| Chemotherapy | 22 | 21 | |
| Chemotherapy + Radiotherapy | 3 | 2 | |
| Postoperative staging | 0.456 | ||
| I | 25 | 27 | |
| II | 18 | 16 | |
| III | 22 | 34 | |
| IVA | 5 | 3 | |
| Concomitant disease | |||
| Hypertension | 20 | 22 | 0.885 |
| Diabetes mellitus | 9 | 12 | 0.706 |
| Cardiovascular disease | 8 | 8 | 0.777 |
| Respiratory disease | 13 | 15 | 0.977 |
Surgical and postoperative characteristics
| Variables | IONM group | Control group |
|
|---|---|---|---|
| Postoperative hospital stay (days) | 8(7,9) | 12(11,15) | <0.001 |
| Total operation time (minutes) | 314.36 ± 70.10 | 309.06 ± 66.49 | 0.636 |
| Estimated blood loss (mL) | 100(100,200) | 100(100,200) | 0.933 |
| Intraoperative blood transfusion | 3 | 2 | 0.544 |
| Conversion to thoracotomy | 1 | 1 | 0.924 |
| Lymph node harvest | |||
| Left RLN | 9.90 ± 5.26 | 6.69 ± 4.51 | <0.001 |
| Right RLN | 3.84 ± 2.03 | 4.33 ± 2.96 | 0.240 |
| Total RLN | 13.74 ± 5.77 | 11.03 ± 5.78 | 0.005 |
| Total thoracic | 28.69 ± 9.23 | 25.03 ± 10.32 | 0.024 |
| Postoperative complications | |||
| VCP | 6(8.6%) | 17(21.3%) | 0.032 |
| Anastomosis leak | 7(10%) | 9(11.3%) | 0.805 |
| Respiratory complications | 5(7.1%) | 15(18.8%) | 0.037 |
| Cardiovascular complications | 3(4.3%) | 3(3.8%) | 0.867 |
| Chylothorax | 1(1.4%) | 2(2.5%) | 0.640 |
| Postoperative mortality | 1(1.4%) | 1(1.4%) | 0.924 |
Results of IONM
| Evaluation with IONM | |||
|---|---|---|---|
| LOS | ROS | − | |
| Motion of vocal cord (POD7) | |||
| + | 2 | 3 | 1 |
| − | 0 | 0 | 64 |
POD, postoperative day.
+, means loss of motion of vocal cord checked by laryngoscopy.
-, means no signs of paralysis checked by laryngoscopy or adequate response on IONM.